tiprankstipranks
Advertisement
Advertisement
Valion Bio names Melinda Lackey as General Counsel
PremiumThe FlyValion Bio names Melinda Lackey as General Counsel
2M ago
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
Premium
Company Announcements
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
3M ago
Alaunos Reports Positive Preclinical Data for Obesity Candidate
Premium
Company Announcements
Alaunos Reports Positive Preclinical Data for Obesity Candidate
4M ago
Alaunos Therapeutics files $50M mixed securities shelf
PremiumThe FlyAlaunos Therapeutics files $50M mixed securities shelf
11M ago
Alaunos Therapeutics Regains Nasdaq Compliance
Premium
Company Announcements
Alaunos Therapeutics Regains Nasdaq Compliance
11M ago
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
Premium
Company Announcements
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
11M ago
Alaunos Therapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsAlaunos Therapeutics Holds Annual Stockholders Meeting
12M ago
Alaunos Therapeutics Appoints Holger Weis as New CEO
Premium
Company Announcements
Alaunos Therapeutics Appoints Holger Weis as New CEO
1y ago
Alaunos Therapeutics Raises $850,000 in Private Offering
Premium
Company Announcements
Alaunos Therapeutics Raises $850,000 in Private Offering
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100